BRCA1-deficient breast cancers are four to eight time less likely to express estrogen alpha receptor (ERα) compared with sporadic breast cancers of similar grade, and tend to lack expression of progesterone, and ErbB2 receptors, that formally defines them as triple-negative tumors11. This evidence concerns the gene BRCA1 and breast cancer.